Elanco Animal Health Incorporated
ELAN
$24.88
-$1.21-4.64%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -276.00M | -34.00M | 11.00M | 67.00M | -8.00M |
| Total Depreciation and Amortization | 168.00M | 168.00M | 161.00M | 152.00M | 154.00M |
| Total Amortization of Deferred Charges | 6.00M | 8.00M | 8.00M | 9.00M | 10.00M |
| Total Other Non-Cash Items | -15.00M | 18.00M | 5.00M | 5.00M | -35.00M |
| Change in Net Operating Assets | 225.00M | 59.00M | 52.00M | -237.00M | 56.00M |
| Cash from Operations | 108.00M | 219.00M | 237.00M | -4.00M | 177.00M |
| Capital Expenditure | -62.00M | -92.00M | -57.00M | -65.00M | -47.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -41.00M |
| Divestitures | 0.00 | 0.00 | 0.00 | 9.00M | 0.00 |
| Other Investing Activities | -2.00M | -9.00M | 1.00M | -2.00M | -2.00M |
| Cash from Investing | -64.00M | -101.00M | -56.00M | -58.00M | -90.00M |
| Total Debt Issued | 1.82B | 290.00M | 0.00 | 250.00M | 0.00 |
| Total Debt Repaid | -2.11B | -188.00M | -446.00M | -178.00M | -38.00M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 273.00M | -255.00M | 290.00M | -20.00M | 6.00M |
| Cash from Financing | -18.00M | -153.00M | -156.00M | 52.00M | -32.00M |
| Foreign Exchange rate Adjustments | 14.00M | 1.00M | 27.00M | 29.00M | -77.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 40.00M | -34.00M | 52.00M | 19.00M | -22.00M |